PMC8628608_01
Imaging studies of the chest.
gr1.jpg
PMC8628608_01_gr1.jpg
fig1
Contrast enhanced computed tomography (CT) of the thorax (Fig. 1A) revealed mainly ground-glass opacities predominantly in the sub-pleural space in the right upper lung lobe. Low-dose chest CT scan revealed progression of lung opacities now involving all lobes of the lung and increasing consolidations of the lung parenchyma in the affected areas (Fig. 1B). Further supporting the notion of rapid overall improvement following administration of Bamlanivimab, CT imaging at discharge (Day 9 after Bamlanivimab administration) showed clear improvement of the consolidating lung opacities (Fig. 1C). A low dose CT showed regressive opacities of the lungs, without any consolidation (Fig. 1D).